Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis

Annals of Neurology

Volumn 57, Issue 2, 2005, Pages 236-251

  Jiang, Yue Mei ^a   Yamamoto, Masahiko ^a   Kobayashi, Yasushi ^a   Yoshihara, Tsuyoshi ^a   Liang, Yideng ^a   Terao, Shinichi ^b   Takeuchi, Hideyuki ^a   Ishigaki, Shinsuke ^a   Katsuno, Masahisa ^a   Adachi, Hiroaki ^a   Niwa, Jun Ichi ^a   Tanaka, Fumiaki ^a   Doyu, Manabu ^a   Yoshida, Mari ^b   Hashizume, Yoshio ^b   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; CASPASE 3; CASPASE 9; CILIARY NEUROTROPHIC FACTOR; DEATH RECEPTOR 5; DYNACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MICROTUBULE ASSOCIATED PROTEIN; SCATTER FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; DNA DETERMINATION; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LASER CAPTURE MICRODISSECTION; MALE; MOTONEURON; MOTOR DYSFUNCTION; MUTATION; NERVE DEGENERATION; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD ATROPHY; SPINAL CORD NERVE CELL; SPINAL CORD VENTRAL HORN; UNINDEXED SEQUENCE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELLS; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LASERS; MALE; MICRODISSECTION; MIDDLE AGED; MOTOR NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 19944432585     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20379     Document Type: Article

References (53)

1. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998;24:104-117.
2. Bunina TL. On intracellular inclusions in familial amyotrophic lateral sclerosis. Korsakov J Neuropath Psychiat 1962;62:1293-1296.
3. Okamoto K, Hirai S, Amari M, et al. Bunina bodies in amyotrophic lateral sclerosi immunostained with rabbit anti-cystatin C serum. Neurosci Lett 1993;162:125-128.
4. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001;2:806-819.
5. Bergeron C. Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis. J Neurol Sci 1995;129(suppl):81-84.
6. Sathasivam S, Ince PG, Shaw PJ. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol 2001;27:257-274.
7. Hand CK, Rouleau GA. Familial amyotrophic lateral sclerosis. Muscle Nerve 2002;25:135-159.
8. Ishigaki S, Liang Y, Yamamoto M, et al. X-Linked inhibitor of apoptosis prorein is involved in murant SOD1-mediated neuronal degeneration. J Neurochem 2002;82:576-584.
9. Kawahara Y, Iro K, Sun H, et al. Gluramate receptors: RNA editing and death of motor neurons. Nature 2004;427:801.
10. Niwa J, Ishigaki S, Hishikawa N, et al. Dorfin ubiquitylates mutant SOD1 and prevents murant SOD1-mediated neuroroxicity. J Biol Chem 2002;277:36793-36798.
11. Hishikawa N, Niwa J, Doyu M, et al. Dorfin localizes to rhe ubiquitylated inclusions in Parkinson's disease, demenria with Lewy bodies, multiple sysrem atrophy, and amyotrophic lateral sclerosis. Am J Parhol 2003;163:609-619.
12. Luo J, Isaacs WB, Trent JM, Duggan DJ. Looking beyond morphology: cancer gene expression profiling using DNA microarrays. Cancer Invest 2003;21:937-949.
13. Alizadeh AA, Ross DT, Perou CM, van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 2001;195:41-52.
14. Luo L, Salunga RC, Guo H, et al. Gene expression profiles of laser-caprured adjacenr neuronal subtypes. Nar Med 1999;5:117-122.
15. Ando Y, Liang Y, Ishigaki S, et al. Caspase-1 and -3 mRNAs are differentially upregulated in motor neurons and glial cells in murant SOD1 transgenic mouse spinal cord: a study using laser microdissection and real-time RT-PCR. Neurochem Res 2003;28:839-846.
16. Ginsberg SD, Hemby SE, Lee VM, et al. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000;48:77-87.
17. Yoshihara T, Ishigaki S, Yamamoto M, et al. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 2002;80:158-167.
18. Kamme F, Salunga R, Yu J, et al. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. J Neurosci 2003;23:3607-3615.
19. Terao S, Sobue G, Hashizume Y, et al. Disease-specific patterns of neuronal loss in rhe spinal ventral horn in amyorrophic lateral sclerosis, multiple system atrophy and X-linked recessive bulbospinal neuronopathy, with special reference to the loss of small neurons in the intermediate zone. J Neurol 1994;241:196-203.
20. Sobue G, Hashizume Y, Yasuda T, et al. Phosphorylated high molecular weight neurofilament prorein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol (Berl) 1990;79:402-408.
21. Bohm M, Wieland I, Schutze K, Rubben H. Microbeam MOMeNT: non-contact laser microdissection of membranemounted native tissue. Am J Pathol 1997;151:63-67.
22. Watanabe H, Tanaka F, Doyu M, et al. Differential somatic CAG repeat instability in variable brain cell lineage in dentatorubral pallidoluysian atrophy (DRPLA): a laser-captured microdissection (LCM)-based analysis. Hum Genet 2000;107:452-457.
23. Schutze K, Lahr G. Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 1998;16:737-742.
24. Wang J, Delabie J, Aasheim H, et al. Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study. BMC Bioinformatics 2002;3:36-44.
25. Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003;102:2951-2959.
26. Malaspina A, Kaushik N, de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 2001;77:132-145.
27. Dangond F, Hwang D, Camelo S, et al. The molecular signature of late-stage human ALS revelated by expression profiling of post-mortem spinal cord gray matter. Physiol Genomics 2004;16:229-239.
28. Kanamori A, Nakayama J, Fukuda MN, et al. Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O-acetylated ganglioside: a putative acetyl-CoA transporter. Pro Natl Acad Sci USA 1997;94:2897-2902.
29. Malisan F, Franchi L, Tomassini B, et al. Acetylation suppresses the proapoptoric activity of GD3 ganglioside. J Exp Med 2002;196:1535-1541.
30. Rapport MM, Donnenfeld H, Brunner W, et al. Ganglioside patterns in amyotrophic lateral sclerosis brain regions. Ann Neuol 1985;18:60-67.
31. Chen HH, Tourtellorte WG, Frank E. Muscle spindle-derived neurotrophin 3 regulates synaptic connectivity between muscle sensory and motor neurons. J Neurosci 2002;22:3512-3519.
32. Mears SC, Frank E. Formation of specific monosynaptic connections between muscle spindle afferenrs and motoneurons in the mouse. J Neurosci 1997;17:3138-3135.
33. Yamamoto M, Sobue G, Yamamoto K, et al. Expression of glial cell line-derived neurotrophic factor mRNA in the spinal cord and muscle in amyotrophic lateral sclerosis. Neurosci Lett 1996;204:117-120.
34. Zhou H, Muramatsu T, Halfter W, et al. A role of midkine in the development of the neuromuscular junction. Mol Cell Neurosci 1997;10:56-70.
35. Oosthuyse B, Moons L, Srorkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001;28:131-138.
36. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003;34:383-394.
37. Gros-Louis F, Laurent S, Lopes AA, et al. Absence of mutations in the hypoxia response element of VEGF in ALS. Muscle Nerve 2003;28:774-775.
38. Kawahara Y, Ito K, Sun H, et al. Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain. Eur J Neurosci 2003;18:23-33.
39. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-1351.
40. Colbert MC, Rubin WW, Linney E, LaMantia AS. Retinoid signaling and the generation of cellular diversity in the embryonic mouse spinal cord. Dev Dyn 1995;204:1-12.
41. Sakakibara S, Okano H. Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J Neurosci 1997;17:8300-8312.
42. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003;33:455-456.
43. Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 1999;2:50-56.
44. Zhang B, Tu P, Abtahian F, et al. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol 1997;139:1307-1315.
45. Farah CA, Nguyen MD, Julien JP, Leclerc N. Altered levels and distribution of microtuble-associated protein before disease onset in a mouse model of amyotrophic lateral sclerosis. J Neurochem 2003;84:77-86.
46. Ideguchi H, Ueda A, Tanaka M, et al. Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM. Biochem J 2002;367:87-95.
47. Hensley K, Floyd RA, Gordon B, et al. Temporal patterns of cytokines and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 2002;82:365-374.
48. Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998;23:249-256.
49. Mu X, He J, Anderson DW, et al. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol 1996;40:379-386.
50. Ekegren T, Grundstrom E, Lindholm D, Aquilonius SM. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons. Acta Neurol Scand 1999;100:317-321.
51. Ranganathan S, Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 2003;162:823-835.
52. Malaspina A, de Belleroche J. Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain Res Brain Res Rev 2004;45:213-229.
53. Sobue G, Sahashi K, Takahashi A, et al. Degenerating compartment and functioning compartment of motor neurons in ALS: possible process of motor neuron loss. Neurology 1983;33:654-657.